News
12-15-2014, 03:16 AM
The German Breast Group (GBG) said nab-paclitaxel (ABRAXANE®) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional solvent-based...
More... (http://www.medicalnewstoday.com/releases/286842.php)
More... (http://www.medicalnewstoday.com/releases/286842.php)